グローバルナビゲーションへ

本文へ

フッターへ



サイトマップ

TOP >  医療関係者の皆様へ >  参考文献

参考文献


禁煙は喫煙関連疾患の予防や改善に役立ち大きな効果をもたらすが、禁煙の継続は容易でなく、喫煙をやめたくてもやめられない喫煙者は多い。
Lopesらが1994年に提唱したモデルを改変したRamstromのタバコ流行モデルを図7に示した81)82)。世界各国におけるタバコ流行は男性の喫煙率の増加(第1期)、男性喫煙率の減少開始と女性(および未成年)の喫煙率の増加(第2期)女性と未成年の喫煙率の減少の開始と喫煙関連疾患死亡の増加(第3期)喫煙関連疾患死亡が減少(第4期)の4つのステージにわけられるが、すでに第4期に達して肺がんなど喫煙関連疾患が減少傾向にある英国やフィンランドと異なり、わが国は女性および未成年の喫煙率の増加がようやく減少に転じ、男女ともに喫煙関連疾患が増加する第3期にある。第3期の喫煙関連疾患の増加はまだ10年以上続くと見られる中、循環器疾患を予防する立場の循環器医師の役割として「喫煙をなくす」ための効果的な働きかけが実施され、非喫煙が当たり前の話となる日の来ることを願ってやまない。
図7:たばことたばこ関連疾患の流行モデル

参考文献

1)厚生労働省 令和元年国民健康・栄養調査結果の概要「第2部 第4章 飲酒・喫煙に関する状況」
https://www.mhlw.go.jp/content/10900000/000687163.pdf

2)Katanoda,K, Marugame T, Saika K, et al: Population Attributable Fraction of Mortality Associated with Tobacco Smoking in Japan: A Pooled Analysis of Three Large-scale Cohort Studies. J Epidemiol. 18:251-264.2008.

3)Peto R, Lopez AD, Boreham J: Mortality from tobacco in developed countries 1950-2000 Oxford Univ Press.1994

4)上島弘嗣:特別報告:1980年循環器疾患基礎調査の追跡研究(NIPPON DATA)日循環協誌 31:231-237,1997 

5)村松茂登彦:たばこの燃焼と煙成分の生成. Health Science, 11(1); 21-28, 1995

6)US Department of Health and Human Service. Cigar, 1998

7)Roberts DL: Nature Tobacco flavor. Recent Adv Tobacco Sci, 14; 49-81, 1988

8)Jarvis MJ , Boreham R, Primatesta P, et al: Nicotine yield from machine-smokes cigarettes and nicotine intakes in smokers. Evidence from a representative population survey. J Natl Cancers Res. 93:134-138, 2001

9)平成11,12年度たばこ煙にふくまれる既知の発がん物質等の有害物質の含量の測定に関する報告書。
厚生労働省保健医療局地域保健・健康増進栄養課

10)Perkins KA, Epstein LH, Jennings. JR, et al: The cardiovascular effects of nicotine during stress. Psychopharmacol, 90:373-378, 1986

11)Allison RD, Roth GM: Central and peripheral vascular effects during cigarette smoking. Arch. Envioron.Health, 19:189-198, 1969

12)Iida M, Iida H, Dohi S, et al: Mechanisms underlying cerebrovascular effects of cigarette smoking in rat in vivo. Stroke 29: 1656-1665, 1998

13)Ohkubo C: Some acute cardio-pulmonary effects of mainstream and sidestream cigarette smoke in man. Prev.Med., 11:173-186, 1982

14)飯田稔他:わが国の循環器疾患の発生におよぼすHDLコレステロールの影響. 厚生の指標,28 (10):3,1981

15)柴田博,須山靖夫,松崎俊久:High Density Lipoproteinコレステロールに関する因子の解析. 日本老年医誌,18:456-462,1981

16)Reed DM, Maclean CJ, Hayashi T: Predictors of atherosclerosis in the Honolulu Heart Program. I. Biologic dietary, and lifestyle characteristics. Am J Epidemiol,136: 214-225,1987

17)Wolf PA, et al: Cigarette smoking as a risk factor for stroke. The Framingham Study.JAMA.259:1025-1029,1988

18)The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project. J Chron Dis 31:201-306, 1978

19) 循環器領域における性差医療に関するガイドライン 班長:鄭 忠和 Circulation J 74, Suppl II, 2010

20) Huxley RR, Woodward M: Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297-1305, 2011

21)Kawachi I, Golditz GA., Stamper MJ, et al: Smoking cessation and decreased risk of stroke in women. JAMA 269; 232-236,1999

22)Smoking and Health US Public Health Service, Report of the Advisory Committee to the Surgeon General of the Public Health Service, DEHW Public Health Service Publ,No.1103,1964

23) 日本呼吸器学会COPDガイドライン作成委員会編 COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン第3版 メデイカルレビュー社 2009

24) 厚生省免疫・アレルギー研究班: 喘息の危険因子.喘息予防・管理ガイドライン 協和企画通信:23-30, 1998

25)Bense L, Eklund G, Wiman LG: Smoking and the increased risk of contracting spontaneous pneumothorax. Chest, 92:1009-1012, 1987

26)丸岡秀一郎、橋本修:発症・進展要因としてのエラスターゼ・アンチエラスターゼ不均衡。日本臨床、57:1982-1987,1999

27)Kato I, Nomura AMY, Stemmermann GN, et al: A prospective study of gastric and duodenal ulcer and its relation to smoking and diet. Am J Epidemiol. 135: 521-530, 1992

28)Kawakami N、Takatsuka N, Shimizu H, et al: Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus:replication and extension in a Japanese cohort of male employees. Am.J Epidemiol, 145:103-109, 1997

29)Savage S, Nagel NJ, Estacio RO, et al: Clinical factors associates with urinary albumin excretion in type II diabetes. Am J Kidney Dis, 126:836-844,1995

30) Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J. 298: 784-8, 1989

31) Nakanishi N, Takatorige T, Suzuki K: Cigarette smoking and the risk of metabolic syndrome in middle-aged Japanese male office workers. Ind Health 43: 295-301, 2005

32) Law MR, Hackshaw AK: A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect BMJ 315: 841-846, 1997

33)Adena MA, Gallagher HG: Cigarette smoking and the age at menopause. Ann. Hum. Biol. 9; 121-130, 1982

34) Ott A, Slooter AJ, Hofman A, et al: Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.
http://www.ncbi.nlm.nih.gov/pubmed?term=smoking%2C%20Lancet%2C%201998%2C%20Rotterdam Lancet 351:1840-1843. 1998

35) California Environmental Protection Agency Health effects of exposure to environmental tobacco smoke: Final draft for scientific, public, and SRP review. Office of Environmental Health Hazard Assessment. California Environmental Protection Agency,1997

36)Steenland K: Passive smoking and the risk of heart disease. JAMA 267 94-99, 1992

37)Otsuka R, Watanabe H, Hirata K et al: Acute effects of passive smoking on coronary circulation in healthy young adults. JAMA; 286:436-441, 2001

38) U.S. Department of Health and Human Survices. 2006 Surgeon General's Report—The Health Consequences of Involuntary Exposure to Tobacco Smoke. Center for Disease Control and Prevention, Coordinationg Center for Health Promotion.National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, 2006

39) Meyers DG, Neuberger JS, He J: Cardiovascular effect of bans on smoking in public places:a systematic review and meta-analysis. J Am Coll Cardiol. 54:1249-1255, 2009

40)Lightwood JM, Grants SA: Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 120:1373-1379, 2009

41) Pell JP, Haw S, Cobbe S,, et al: Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008.

42)禁煙ガイドライン(2010年改訂版)
https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2010murohara.h.pdf

43)急性冠症候群診療ガイドライン(2018年改訂版)
https://www.j-circ.or.jp/cms/wp-content/uploads/2018/11/JCS2018_kimura.pdf

44)2023年改訂版 冠動脈疾患の一次予防に関する診療ガイドライン
https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_fujiyoshi.pdf

45)Howe G, Westhoff C, Vessey M et al: Effects of age, cigarette smoking and other factors on fertility. Findings in a large prospective study. BMJ. 290; 1697-1700, 1985

46)斎藤麗子: 妊婦と夫の喫煙状況と出生時への影響。日本公衛誌 38:124-131,1991

47)Frazier T M. Davis G H, Goldstein H et al: Cigarette Smoking and Prematurity: a Prospective study. Am.J. Obstet. Gynecol. 81(5): 988-996, 1961

48)田中 哲郎: 乳幼児死亡の防止に関する研究 平成9年度厚生省心身障害研究

49)伊藤桂子,竹内さよ,小川浩他:家族の喫煙と小児の呼吸器疾患について(第2報)日本公衛誌28:493,1981

50)Longo DR, Feldman MM, Kruse RL, et al: Implementing smoking bans in American hospitals: results of a national survey. Tob Control 7: 47-55, 1998.

51)平山雄 : 喫煙と動脈硬化の関係に関する疫学的研究ー約27万人の40歳以上の成人の13年間継続観察成績を中心に。最新医学36:798,1981

52)Wolf PA,D’Agostino RB, Kannel WB, et al: Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA.259:1025-1029,1988

53)Salonen JT: Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J, 43:463-469,1980

54)Sato I, Nishida M, Okita K,et al: Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction. Jpn Circ J, 56:217-222,1992

55)Voors AA, van Brussel BL, Plokker HW, et al: Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation. 93(1):42-47. 1996

56)Rose G, Hamilton PJ, Colwell L, et al: A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 36(2):102-108, 1982

57)Wingo PA, Ries LA, Rosenberg HM, et al: Cancer incidence and mortality, 1973-1995: a report card for the U.S.Cancer. 82(6): 1197-1207. 1998

58)Wingo PA, Ries LA, Giovino GA, et al: Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 91(8): 675-690. 1999

59)中原俊隆、望月友美子:たばこによる社会損失 厚生の指標、42(11):3-10、1995

60)医療経済研究機構 喫煙製作のコストベネフィット分析にかかわる調査研究報告書 63-106、1998

61)後藤公彦: たばこの経済分析 日本医師会雑誌 116(4)、370-374,1996

62) Balfour DJK: Neural mechanisms underlying nicotine dependence. Addiction 89: 1419-1423, 1994

63)Russrl MAH: The smoking habit and its classification. Practitioner 212: 781-800,1974

64)McNeill AD: The development of dependence on smoking in children. Br.J Addiction, 86: 589-592,1991

65)日本循環器学会,日本肺癌学会,日本癌学会,日本呼吸器学会 編:禁煙治療のための標準手順書 第8.1版.2021.

66) Kawakami N, Takatsuka N, Inaba S, Shimizu H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav. 24: 155-166, 1999

67)Fagerstrom KO, Schneider NG: Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12: 159-182, 1989.

68)Prochaska JO, Velicer WF: The transtheoretical model of health behavior change. Am J Health Promot 12: 38-48, 1997.

69)Hartmann-Boyce J, Chepkin SC, Ye W, et al: Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 2018, 5: CD000146, 2018.

70) Cahill K, Lindson-Hawley N, Thomas KH, et al: Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 5: CD006103, 2016.

71)五島雄一郎,兼本成斌,並木正義,他:喫煙関連疾患を有する喫煙者での喫煙補助薬Ba37142(Nicotine TTS)の臨床効果-多施設協同第Ⅲ相二重盲検比較試験-.臨床医薬10:1801-1830, 1994.

72)Hays JT, Croghan IT, Schroeder DR, et al: Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health; 89:1701-1709, 1999.

73)Schneider NG, Jarvik ME, Forsythe AB, et al: Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 8: 253-261, 1983.

74) Tapper AR, McKinney SL, Nashmi R, et al: Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science. 306: 1029-1032, 2004

75) Nakamura M, Oshima A, Fujimoto Y, et al: Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther. 29:1040-1056, 2007

76)あなたにもできる禁煙ガイド PASSPORT to STOP SMOKING 第3版 日本循環器学会禁煙推進委員会企画・発行 2008
https://www.j-circ-kinen.jp//textbook/001/index.html

77)ビジュアル教材「今から始める喫煙防止教育」[第2版] 企画・著作:団法人日本循環器学会 禁煙推進委員会
https://www.j-circ-kinen.jp//textbook/004/index.html

78)中村正和、大島明、増居志津子:らくらく禁煙ブック-あなたも無理なくタバコがやめられる 法研 東京 2008

79)高橋裕子:ポジテイブ禁煙 東京法規出版 東京 2009

80)日本心臓財団:禁煙のすすめ-タバコをやめようかなと思っている方へ 2011

81)Ramstrom LM: Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 5(1):52-56. 1996

82) Ramstrom LM: Prevalence and other dimensions of smoking in the world. In Bollinger CT, Fagerstrom KO(eds): The Tobacco Epidemic. Prog. Respir. Res. 28: 64-77, 1997